New Frontiers in Therapeutics for Interstitial Lung Diseases.
作者信息
Mesfin Nathan, Sangani Ruchika, Shankar Divya A, Reardon Christine
机构信息
The Pulmonary Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts.
出版信息
Am J Respir Crit Care Med. 2023 Apr 15;207(8):1089-1091. doi: 10.1164/rccm.202206-1035RR.
Abstract
摘要
相似文献
1
New Frontiers in Therapeutics for Interstitial Lung Diseases.间质性肺疾病治疗新前沿
Am J Respir Crit Care Med. 2023 Apr 15;207(8):1089-1091. doi: 10.1164/rccm.202206-1035RR.
2
[Treatment in diffuse interstitial lung diseases].
Tuberk Toraks. 2005;53(2):190-9.
3
Immunosuppressive treatment of the pulmonary manifestations of progressive systemic sclerosis.进行性系统性硬化症肺部表现的免疫抑制治疗。
Curr Opin Rheumatol. 1995 May;7(3):174-82. doi: 10.1097/00002281-199505000-00004.
4
Interstitial lung abnormalities: ignotum per ignotius.间质性肺异常：以未知解释未知。
Lancet Respir Med. 2019 May;7(5):376-378. doi: 10.1016/S2213-2600(19)30052-9. Epub 2019 Mar 29.
5
[Cyclosporin and diffuse alveolar interstitial lung disease].[环孢素与弥漫性肺泡间质肺疾病]
Arch Bronconeumol. 1996 Jun-Jul;32(6):302-6.
6
[Idiopathic bronchiolocentric interstitial pneumonia: a new idiopathic interstitial pneumonia].特发性细支气管中心性间质性肺炎：一种新的特发性间质性肺炎
Arch Bronconeumol. 2007 Aug;43(8):464-6. doi: 10.1016/s1579-2129(07)60104-9.
7
Immunosuppressive agents and interstitial lung disease: what are the risks?
Expert Rev Respir Med. 2014 Jun;8(3):263-6. doi: 10.1586/17476348.2014.880054. Epub 2014 Mar 20.
8
Interstitial lung disease in children.儿童间质性肺疾病
Indian Pediatr. 2013 Jan 8;50(1):59-60. doi: 10.1007/s13312-013-0009-0.
9
Children's interstitial and diffuse lung disease.儿童间质性和弥漫性肺疾病。
Lancet Child Adolesc Health. 2019 Aug;3(8):568-577. doi: 10.1016/S2352-4642(19)30117-8. Epub 2019 Jun 18.
10
Nintedanib for systemic sclerosis-associated interstitial lung disease.尼达尼布用于治疗系统性硬化症相关间质性肺疾病。
Lancet Respir Med. 2020 Feb;8(2):136. doi: 10.1016/S2213-2600(20)30001-1. Epub 2020 Jan 10.
本文引用的文献
1
Therapeutic Targeting of the Respiratory Microbiome.呼吸道微生物群的治疗靶向
Am J Respir Crit Care Med. 2022 Sep 1;206(5):535-544. doi: 10.1164/rccm.202112-2704PP.
2
Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial lung disease (PF-ILD).BMS-986278 治疗特发性肺纤维化（IPF）或进行性纤维化间质性肺疾病（PF-ILD）患者的 2 期临床试验设计，BMS-986278 是一种溶血磷脂酸受体 1（LPA）拮抗剂。
BMJ Open Respir Res. 2021 Dec;8(1). doi: 10.1136/bmjresp-2021-001026.
3
Effect of Antimicrobial Therapy on Respiratory Hospitalization or Death in Adults With Idiopathic Pulmonary Fibrosis: The CleanUP-IPF Randomized Clinical Trial.抗微生物治疗对特发性肺纤维化成人患者呼吸住院或死亡的影响：CleanUP-IPF 随机临床试验。
JAMA. 2021 May 11;325(18):1841-1851. doi: 10.1001/jama.2021.4956.
4
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial.吡非尼酮治疗非特发性肺纤维化的进展性肺纤维化间质性肺疾病患者（RELIEF）：一项双盲、随机、安慰剂对照、2b 期试验。
Lancet Respir Med. 2021 May;9(5):476-486. doi: 10.1016/S2213-2600(20)30554-3. Epub 2021 Mar 30.
5
Effect of Co-trimoxazole (Trimethoprim-Sulfamethoxazole) vs Placebo on Death, Lung Transplant, or Hospital Admission in Patients With Moderate and Severe Idiopathic Pulmonary Fibrosis: The EME-TIPAC Randomized Clinical Trial.复方新诺明（甲氧苄啶-磺胺甲噁唑）与安慰剂对中重度特发性肺纤维化患者死亡、肺移植或住院的影响：EME-TIPAC 随机临床试验。
JAMA. 2020 Dec 8;324(22):2282-2291. doi: 10.1001/jama.2020.22960.
6
Target inhibition of galectin-3 by inhaled TD139 in patients with idiopathic pulmonary fibrosis.特发性肺纤维化患者经吸入 TD139 靶向抑制半乳糖凝集素-3。
Eur Respir J. 2021 May 27;57(5). doi: 10.1183/13993003.02559-2020. Print 2021 May.
7
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.尼达尼布治疗进行性纤维化间质性肺疾病。
N Engl J Med. 2019 Oct 31;381(18):1718-1727. doi: 10.1056/NEJMoa1908681. Epub 2019 Sep 29.
8
The natural course of lung function decline in asbestos exposed subjects with pleural plaques and asbestosis.石棉暴露个体伴胸膜斑和石棉肺时肺功能下降的自然病程。
Respir Med. 2019 Jul-Aug;154:82-85. doi: 10.1016/j.rmed.2019.06.013. Epub 2019 Jun 13.
9
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease.尼达尼布治疗系统性硬化症相关间质性肺疾病。
N Engl J Med. 2019 Jun 27;380(26):2518-2528. doi: 10.1056/NEJMoa1903076. Epub 2019 May 20.
10
Pragmatic Trials.实用性试验
N Engl J Med. 2016 Aug 4;375(5):454-63. doi: 10.1056/NEJMra1510059.
Zotero 插件